Delivery Order SPE2DB20D9127-SPE2DB21FY22L
- Not listed
- This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a delivery order under the Defense Logistics Agency's (DLA) SPE2DB Indefinite Delivery Contract (IDC) valued at $499,999,999. The contract covers a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the medical supply needs of military health facilities worldwide. The current...
- This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a delivery order under the Defense Logistics Agency's (DLA) SPE2DB Indefinite Delivery Contract (IDC) valued at up to $499,999,999. The contract provides for the supply of a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the recurring medical supply...
- This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a delivery order under the Defense Logistics Agency's (DLA) SPE2DB Indefinite Delivery Contract (IDC) valued at $499,999,999. The contract covers the provision of a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the recurring medical supply needs of military healthcare...
- This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is for a Firm Fixed Price delivery order under the Defense Logistics Agency's (DLA) SPE2DB Indefinite Delivery Contract (IDC) worth up to $499,999,999. Through this IDC, the DLA can issue delivery orders for a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the medical supply...
- This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a firm fixed-price delivery order under the Defense Logistics Agency's (DLA) SPE2DB Indefinite Delivery Contract (IDC). The IDC is valued at $499,999,999 and is valid through November 2026, enabling the DLA to issue delivery orders for a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to...
- This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, was issued by the Defense Logistics Agency (DLA) as a delivery order under the SPE2DB Indefinite Delivery Contract (IDC) valued at $499,999,999 and valid through November 2026. The contract provides the DLA with a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to...
- This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a delivery order under a larger indefinite delivery contract (IDC) with the Defense Logistics Agency (DLA) valued at up to $499,999,999. The IDC, under the SPE2DB program, allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items, including both common and specialized medications, to fulfill the recurring medical supply needs of Department of Defense...
- This federal contract award is for pharmaceutical products and medical supplies provided by DMS Pharmaceutical Group Inc., a woman-owned small business, to the Defense Logistics Agency (DLA). The contract is a single-award Indefinite Delivery Contract (IDC) under the SPE2DB program, valued at $499,999,999 and valid through November 2026. The contract covers a comprehensive range of pharmaceutical items, including branded and generic prescription drugs, over-the-counter medications, biologics,...
- This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a delivery order valued at $78,006.06 for pharmaceutical products and medical supplies. The award was made by the Defense Logistics Agency (DLA), a defense agency, under the SPE2DB indefinite delivery contract (IDC) program, which has a total potential value of $499,999,999 and is valid through November 2026. The contract covers a comprehensive range of pharmaceutical items, including branded and...
- This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a firm fixed-price delivery order valued at $11,587.21. The award was made by the Defense Logistics Agency (DLA) under the Medical Supply Chain program to provide a wide range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to support the recurring medical supply needs of military...
- SPE2DB20D9127Indefinite Delivery Contract
- SPE2DB20D9127-SPE2DB21FY22LDelivery Order
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a delivery order (SPE2DB21FY22L) issued by the Defense Logistics Agency (DLA) under a larger Indefinite Delivery Contract (IDC) valued at $499,999,999. The IDC, which is valid through November 2026, enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the medical supply needs of military health facilities worldwide. The current delivery order (SPE2DB20D9127) has a ceiling value of $1,629.60 and covers the provision of pharmaceutical products and medical supplies to the DLA's Philadelphia branch. The contract is not associated with any set-aside designation, allowing DMS Pharmaceutical Group to leverage its woman-owned small business status to secure direct federal awards across multiple product categories and medical domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 12/23/20 |